Effect of Retro walking as an Adjunct to conventional treatment on Pain, Balance, Gait, Muscle strength, Flexibility, Functional disability and Mobility in patients with knee Osteoarthritis
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- c)Balance parameters ( including COP sway, COP range, Proprioception, Reaction time, & Multidimensional stability) using pedalosensa move
研究概览
简要总结
**Aim:**The Objective of this RCT is to evaluate the effects of retro walking when used as an adjunct to Conventional treatment on pain, balance, gait, functional disability and mobility, muscle strength, and flexibility, in patients with OA knee compared to conventional treatment alone
Background and need of study: There is enough evidence demonstrating the effect of retro walking on pain and knee functional disability and mobility in patients with OA knee as it reduces the compressive
load on the knee but studies regarding its effect on gait, balance, muscle strength, and flexibility are inadequate as they involve the measurement of few parameters and use of conventional measuring tools. Considering this, the present study aims to investigate the effect of retro walking on strength, biomechanical gait, and balance parameters using more advanced tools in patients with knee OA.
Methods: An single -blinded randomized control trial on patients with OA knee (age 40 and above, both male and female) will be conducted in CPRS, Jamia Millia Islamia, New Delhi in accordance with the declaration of Helsinki, 1964. Considering a 12 % drop out 42 eligible patients will be randomly allocated to either group A(n=21) which will receive conventional treatment including IFT for 15 min, a supervised exercise program that includes straight leg raising, isometric quadriceps, isometric hip adduction, terminal knee extension, semi-squat, and isotonic quadriceps exercise and home program and group B(n=21) which will receive 15 min of retro walking on the treadmill along with conventional treatment for 3days /week for 6 weeks. Primary outcome measures include balance parameters (cop sway, cop range, reaction time, multidirectional stability, and proprioception), gait parameters (walking velocity, stride length, stride time, step width, step time and cadence), muscle strength (quadriceps to hamstring ratio, hip flexors to hip extensors ratio), pain intensity will be measured using pedalosensa move, kinovea software, Lafayette dynamometer and NPRS. Secondary outcome measures include hamstring flexibility, and knee function score using the KOOS scale and TUG score. Assessment of outcome measures includes pain intensity, muscle strength, flexibility, balance, kinematic gait parameters, functional disability, and mobility at baseline, after 3rd week, and immediately after post-intervention.
Conclusion and clinical implication: Findings will provide evidence on the effectiveness of retro walking and help to enhance its future implementation to conventional treatment. The study might lead to new scientific insights into the importance of retro walking in the rehabilitation of patients with OA knee. This study will help us to understand the correlation between retro walking and conventional treatment for knee osteoarthritis. It will explore and provide information about retro walking and to which extent it affects balance parameters, gait parameters, strength, flexibility, function and pain. Retro-walking could be a useful technique for improving balance, gait, function, strength of the quadriceps and hip extensors, hamstring flexibility and reduce pain when used as an adjunct to conventional treatment. Since retro-walking prevents overstretching of the ligaments and undue loading of the knee, it may be proved as a good training method for rehabilitation of patients with OA knee. As the prevalence of OA knee is increasing its importance to keep up to date for providing best treatment for reducing pain and improving function through evidence-based practice and this study could provide knowledge of body for the same. To benefit knee OA patients, it is crucial to provide them with adequate rehabilitation training to decrease pain and enhance their strength and balance. This study guides us through the new treatment approach for patients with OA knee. Findings from this study may be relevant for the development of treatment strategies for patient with OA knee.
Ethical approval: The study has been approved by Institutional Human Ethical Committee, Jamia Millia Islamia, India.
研究设计
- 研究类型
- Interventional
- 分配方式
- Permuted block randomization, fixed
- 盲法
- Outcome Assessor Blinded
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •a) Individuals fulfilling, clinical criteria listed by the American College of Rheumatology: knee pain and any three out of the following six criteria (age >50 years; morning stiffness lasting <30 min; crepitus on active motion; bony tenderness; bony enlargement; and no warmth on touch (Wu CW, et al.
- •b)Individuals on Grade 2 and 3 or mild to moderate as per Kellgren and Lawrence scale.
- •c)Individuals with knee pain for more than 6 weeks.
- •d)Age: above 40 (male and female).
- •e)Patient with body mass index less than 25 kg/m2 f)In case of bilateral involvement more severely involve knee will be considered.
- •g)Patients with pain less than 7 or equal to 3 or more on the Numerical Pain Rating Scale.
排除标准
- •Individuals will be excluded from the study if they will have.
- •a)Any underlying pathology, History of ankle disease, Congenital deformities, other systemic arthritis, recent surgeries, trauma, or fractures of the lower limb b)Known cases of severe osteoporosis.
- •c)With any neurological disorder including balance issues and motor and sensory loss.
- •d)Taking intraarticular injection for knee pain for the last 6 months e)Presence of acute joint effusion f)Individuals having visual dysfunction or refractory errors are not corrected with glasses or contact lenses.
- •g)Individuals having baseline history of established coronary artery disease (CAD), typical angina or heart failure.
- •h)Patient with metal implant or cardiac pacemaker.
- •i)Patients with uncontrolled arterial hypertension, atrial fibrillation or flutter, hypertrophic and dilated cardiomyopathy, valvular heart disease, cerebrovascular disease (history of stroke, transient ischemic attacks, or carotid artery surgery), are contraindicated to the exercise test were not included in the study.
- •(American College of Sports Medicine.
- •ACSM’s Guidelines for Exercise Testing and Prescription (8th edition).
结局指标
主要结局
c)Balance parameters ( including COP sway, COP range, Proprioception, Reaction time, & Multidimensional stability) using pedalosensa move
时间窗: week 0 , after 3rd week & after completion of 6th week
a)Pain intensity on the NPRS scale,
时间窗: week 0 , after 3rd week & after completion of 6th week
b)Kinematic parameters of Gait( including Stride length, Step length, Stride time, Step time, Gait velocity & Cadence) using kinovea software
时间窗: week 0 , after 3rd week & after completion of 6th week
d)Muscle strength ( hip flexor to hip extensor strength ratio & quadriceps to hamstring strength ratio ) using Lafayette dynamometer
时间窗: week 0 , after 3rd week & after completion of 6th week
次要结局
- a)Functional disability score using KOOS scale,(b)Functional mobility using Time up & go test, & muscle c) muscle flexibility)
